Importantly, NCOA4-RET G810R tumour growth remained virtually unaffected by 0.3 and 1 mg/Kg doses; only 3 mg/Kg treatment was able to reduce tumour volume by about 50%. This evidence concerns the gene NCOA4 and neoplasm.